97765090 - CENCORA

Information

  • Trademark
  • 97765090
  • Serial Number
    97765090
  • Filing Date
    January 23, 2023
    2 years ago
  • Transaction Date
    May 22, 2025
    5 months ago
  • Status Date
    February 04, 2025
    9 months ago
  • Published for Opposition Date
    June 11, 2024
    a year ago
  • Location Date
    August 06, 2024
    a year ago
  • Status Code
    730
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    EUBANK, REBECCA
  • Attorney Docket Number
    028581.0419
    Attorney Name
    Anita B. Polott
    Law Office Assigned Location Code
    M70
  • Owners
Mark Drawing Code
4
Mark Identification
CENCORA
Case File Statements
  • GS0441: Medical analysis services; Medical analysis services, namely, analyzing and reporting in the field of human disease treatment; providing a secured-access internet website for medical professionals and medical patients featuring medical information and analysis of patient data in the field of oncology care practices, namely, the specific diagnosis, line of therapy, stage of disease and regimen; providing clinical and home health care services, namely, providing information relating to therapeutic properties of pharmaceuticals; providing counseling to patients in the field of administration of medications; providing a secured-access internet website for medical professionals and medical patients featuring medical information and analysis of patient data in the field of oncology care practices, namely, the specific diagnosis, line of therapy, stage of disease and regimen; providing clinical and home health care services; providing clinical and home health care services, namely, providing information relating to therapeutic properties of pharmaceuticals; providing counseling to patients in the field of administration of medications; providing medical provider and care information; providing wellness programs for disease treatment and management featuring patient-centered incentives for compliance with physician-directed educational, medication therapy, and home care programs; information services for the pharmaceutical and medical sectors; counseling services related to workplace and personnel health; healthcare services; services of information on medical substances; analysing and reporting of discussions about human disease treatment; administration and management of sophisticated pharmaceutical therapies; providing a website featuring customisable information and analysis about legislative regulatory developments in the field of healthcare; telehealth services, namely, healthcare services provided via telecommunication in the nature of remote monitoring of data indicative of the health or condition of a patient for medical treatment purposes; telehealth services, namely, providing patients with health information relating to their medical condition; beauty and health care advice services; providing nursing services to others on behalf of pharmaceutical and biotechnology companies; Providing information on health and nutrition in the field of animal management; consulting services in the field of animal husbandry, medical and healthcare management, namely, medical research, development, analysis and identification of processes to efficiently raise individual animals; providing a website featuring information to retail customers of pharmacies over a global computer network with regard to health, wellness and pharmacy news; providing information, news and commentary in the field of current events relating to the healthcare industry and healthcare legislation and regulation; providing on-line information, news and commentary in the field of health and wellness relating to healthy diets and activities for male and female infants, children, teenagers, adults and seniors and to illnesses and treatments affecting them; pharmaceutical consultation; providing medical information
Case File Event Statements
  • 10/19/2023 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/26/2023 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 2/13/2023 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/18/2023 - 2 years ago
    3 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 10/24/2023 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/24/2023 - 2 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/24/2023 - 2 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/16/2024 - a year ago
    8 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 1/16/2024 - a year ago
    9 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 4/18/2024 - a year ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/18/2024 - a year ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/18/2024 - a year ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/18/2024 - a year ago
    13 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 4/18/2024 - a year ago
    14 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 5/9/2024 - a year ago
    15 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 5/9/2024 - a year ago
    16 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 5/9/2024 - a year ago
    17 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 5/9/2024 - a year ago
    18 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 5/9/2024 - a year ago
    19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/22/2024 - a year ago
    20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/11/2024 - a year ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/6/2024 - a year ago
    23 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 6/11/2024 - a year ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/4/2025 - 9 months ago
    24 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 2/4/2025 - 9 months ago
    25 - SOU EXTENSION 1 FILED Type: EXT1
  • 2/5/2025 - 9 months ago
    26 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 2/5/2025 - 9 months ago
    27 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA